Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From Genmab A/S
Big pharma business development executives forecast a competitive and active deal-making year ahead for the industry at the Biocom partnering conference.
The latest drug development news and highlights from the Pink Sheet’s US FDA Performance Tracker
The company's CEO talked to Scrip about the expected US launch of tisotumab vedotin likely later in 2021 and the company's partnering strategy going forward.
Another promising British-based company, GW Pharma, has been acquired, this time by mid-sized US player Jazz. Is it a pipedream that a UK biotech could be in a position to pull off a $7bn takeover of its own or does it really not matter?
- Large Molecule